Atlas Trials

A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

Clinical trial NCT01264367 · COMPLETED

Trial details

NCT number
NCT01264367
Sponsor
Bukwang Pharmaceutical
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HBeAg(+) Chronic Hepatitis B
Start date
2008-12-01
Primary completion
2013-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.